Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v2-FR
Language French French
Date Updated 2020-02-13 2019-11-21
Drug Identification Number 02270226 02270226
Brand name TEVA-BICALUTAMIDE TEVA-BICALUTAMIDE
Common or Proper name TEVA-BICALUTAMIDE 50MG TAB TEVA-BICALUTAMIDE 50MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BICALUTAMIDE BICALUTAMIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code L02BB L02BB
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-20 2019-11-20
Estimated end date 2020-03-31 2019-12-31
Actual end date 2020-02-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments